{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-029022","form_type":"8-K","ticker":"STSS","cik":"0001737995","company_name":"Sharps Technology Inc.","filed_at":"2024-07-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.366132+00:00","generated_at":"2026-05-31T16:20:21.863839+00:00","sec_items":["1.01","7.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Sharps Technology enters 5-year deal for 520M syringes, selling out EU facility capacity","bullets":["5-year supply agreement with Stericare Solutions for 520M units of 10mL SoloGard syringes.","Expected revenue exceeds $50M; first delivery targeted November 2024.","Agreement sells out current manufacturing capacity for 10mL SoloGard at EU facility.","Customer is a U.S. supplier of medical saline/water products; evaluation triggered by FDA recalls and Chinese syringe tariffs.","Q4 2024 revenue ramp begins; company to expand EU facility for future growth."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-029022","json":"https://secwatch.observer/filing/0001493152-24-029022.json","markdown":"https://secwatch.observer/filing/0001493152-24-029022.md","text":"https://secwatch.observer/filing/0001493152-24-029022.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1737995/000149315224029022/0001493152-24-029022-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1737995/000149315224029022/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T16:20:21.863839+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}